Hisham Moussa

Chief Investment Officer at The Sovereign Fund of Egypt

Hisham Moussa has extensive work experience in various roles and industries. Hisham currently holds the position of Chief Investment Officer at The Sovereign Fund of Egypt, where they have been since 2021. Prior to this, they served as the Chief Executive Officer of the Healthcare and Pharma Subfund and as a Board Member for the Healthcare and Pharma Fund within the same organization.

Before joining The Sovereign Fund of Egypt, Hisham Moussa worked as a Board Member at Afriglobal Medicare starting from 2019. Hisham also served as the Managing Partner at Alpha Square Partners from 2018 to 2021 and as a Board Member at AL TAYSEER HEALTHCARE GROUP from 2018 to 2021.

Furthermore, Hisham Moussa held the position of Partner at Zoser Capital Partners from 2020 to 2021. Hisham gained valuable experience during their tenure at The Abraaj Group, where they served as the Managing Director of Healthcare from 2015 to 2017, Director of Performance Acceleration Group - MENA from 2012 to 2014, Vice President of the Investment Team from 2009 to 2012, and Assistant Vice President of the Investment Team from 2007 to 2009.

Additionally, Hisham Moussa has previous experience working at HSBC Global Banking and Markets as an Associate in Investment Banking from 2004 to 2007 and at KPMG as a Consultant in Corporate Finance from 2003 to 2004.

Early in their career, they worked as a Senior Financial Analyst at OKAZ Investments from 2001 to 2003 and as an Accountant at Raya Holding from 2000 to 2001.

Overall, Hisham Moussa has held various leadership and board positions across different organizations, demonstrating their expertise in investment, healthcare, and finance.

Hisham Moussa holds a Bachelor's degree in Accounting and Finance from Cairo University, which they obtained from 1996 to 2000. Prior to that, they completed their secondary education and obtained an International General Certificate for Secondary Education (IGCSE) from Education Home between 1993 and 1996. In 2003, they obtained the Chartered Financial Analyst (CFA) certification from the CFA Institute.

Links

Previous companies

HSBC logo
KPMG logo

Timeline

  • Chief Investment Officer

    August, 2023 - present

  • Chief Executive Officer, Healthcare And Pharma Subfund

    November, 2021

  • Board Member - Healthcare And Pharma Fund

    February, 2021